Literature DB >> 25008914

Influenza A and B virus intertypic reassortment through compatible viral packaging signals.

Steven F Baker1, Aitor Nogales1, Courtney Finch2, Kevin M Tuffy1, William Domm1, Daniel R Perez2, David J Topham3, Luis Martínez-Sobrido4.   

Abstract

UNLABELLED: Influenza A and B viruses cocirculate in humans and together cause disease and seasonal epidemics. These two types of influenza viruses are evolutionarily divergent, and exchange of genetic segments inside coinfected cells occurs frequently within types but never between influenza A and B viruses. Possible mechanisms inhibiting the intertypic reassortment of genetic segments could be due to incompatible protein functions of segment homologs, a lack of processing of heterotypic segments by influenza virus RNA-dependent RNA polymerase, an inhibitory effect of viral proteins on heterotypic virus function, or an inability to specifically incorporate heterotypic segments into budding virions. Here, we demonstrate that the full-length hemagglutinin (HA) of prototype influenza B viruses can complement the function of multiple influenza A viruses. We show that viral noncoding regions were sufficient to drive gene expression for either type A or B influenza virus with its cognate or heterotypic polymerase. The native influenza B virus HA segment could not be incorporated into influenza A virus virions. However, by adding the influenza A virus packaging signals to full-length influenza B virus glycoproteins, we rescued influenza A viruses that possessed HA, NA, or both HA and NA of influenza B virus. Furthermore, we show that, similar to single-cycle infectious influenza A virus, influenza B virus cannot incorporate heterotypic transgenes due to packaging signal incompatibilities. Altogether, these results demonstrate that the lack of influenza A and B virus reassortants can be attributed at least in part to incompatibilities in the virus-specific packaging signals required for effective segment incorporation into nascent virions. IMPORTANCE: Reassortment of influenza A or B viruses provides an evolutionary strategy leading to unique genotypes, which can spawn influenza A viruses with pandemic potential. However, the mechanism preventing intertypic reassortment or gene exchange between influenza A and B viruses is not well understood. Nucleotides comprising the coding termini of each influenza A virus gene segment are required for specific segment incorporation during budding. Whether influenza B virus shares a similar selective packaging strategy or if packaging signals prevent intertypic reassortment remains unknown. Here, we provide evidence suggesting a similar mechanism of influenza B virus genome packaging. Furthermore, by appending influenza A virus packaging signals onto influenza B virus segments, we rescued recombinant influenza A/B viruses that could reassort in vitro with another influenza A virus. These findings suggest that the divergent evolution of packaging signals aids with the speciation of influenza A and B viruses and is in part responsible for the lack of intertypic viral reassortment.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25008914      PMCID: PMC4178878          DOI: 10.1128/JVI.01440-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Inhibition of influenza A virus replication by influenza B virus nucleoprotein: an insight into interference between influenza A and B viruses.

Authors:  Asawin Wanitchang; Jaraspim Narkpuk; Peera Jaru-ampornpan; Juggagarn Jengarn; Anan Jongkaewwattana
Journal:  Virology       Date:  2012-07-06       Impact factor: 3.616

2.  A distinct lineage of influenza A virus from bats.

Authors:  Suxiang Tong; Yan Li; Pierre Rivailler; Christina Conrardy; Danilo A Alvarez Castillo; Li-Mei Chen; Sergio Recuenco; James A Ellison; Charles T Davis; Ian A York; Amy S Turmelle; David Moran; Shannon Rogers; Mang Shi; Ying Tao; Michael R Weil; Kevin Tang; Lori A Rowe; Scott Sammons; Xiyan Xu; Michael Frace; Kim A Lindblade; Nancy J Cox; Larry J Anderson; Charles E Rupprecht; Ruben O Donis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

3.  The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses.

Authors:  Natalie Pica; Arun Iyer; Irene Ramos; Nicole M Bouvier; Ana Fernandez-Sesma; Adolfo García-Sastre; Anice C Lowen; Peter Palese; John Steel
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

4.  The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response.

Authors:  Emilio Ortiz-Riaño; Benson Yee Hin Cheng; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

5.  A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.

Authors:  Rong Hai; Adolfo García-Sastre; David E Swayne; Peter Palese
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

6.  Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.

Authors:  Rafael A Medina; Balaji Manicassamy; Silke Stertz; Christopher W Seibert; Rong Hai; Robert B Belshe; Sharon E Frey; Christopher F Basler; Peter Palese; Adolfo García-Sastre
Journal:  Nat Commun       Date:  2010-06-15       Impact factor: 14.919

7.  Influenza viruses with rearranged genomes as live-attenuated vaccines.

Authors:  Lindomar Pena; Troy Sutton; Ashok Chockalingam; Sachin Kumar; Matthew Angel; Hongxia Shao; Hongjun Chen; Weizhong Li; Daniel R Perez
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

8.  Protection against lethal influenza with a viral mimic.

Authors:  Steven F Baker; Hailong Guo; Randy A Albrecht; Adolfo García-Sastre; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

9.  A supramolecular assembly formed by influenza A virus genomic RNA segments.

Authors:  Emilie Fournier; Vincent Moules; Boris Essere; Jean-Christophe Paillart; Jean-Daniel Sirbat; Catherine Isel; Annie Cavalier; Jean-Paul Rolland; Daniel Thomas; Bruno Lina; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

10.  An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus.

Authors:  Cyrille Gavazzi; Catherine Isel; Emilie Fournier; Vincent Moules; Annie Cavalier; Daniel Thomas; Bruno Lina; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2012-12-05       Impact factor: 16.971

View more
  47 in total

1.  Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.

Authors:  Aitor Nogales; Laura Rodriguez; Marta L DeDiego; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).

Authors:  Steven F Baker; Aitor Nogales; Felix W Santiago; David J Topham; Luis Martínez-Sobrido
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641

3.  Identification of a Type-Specific Promoter Element That Differentiates between Influenza A and B Viruses.

Authors:  Shuman Gao; Wenyu Zhang; Congyu Lu; Mengmeng Cao; Shan Cen; Yousong Peng; Tao Deng
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

4.  Heterologous Packaging Signals on Segment 4, but Not Segment 6 or Segment 8, Limit Influenza A Virus Reassortment.

Authors:  Maria C White; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

5.  Replication-competent influenza A viruses expressing a red fluorescent protein.

Authors:  Aitor Nogales; Steven F Baker; Luis Martínez-Sobrido
Journal:  Virology       Date:  2014-12-30       Impact factor: 3.616

6.  Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.

Authors:  Steven F Baker; Aitor Nogales; Luis Martínez-Sobrido
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

Review 7.  Development and applications of single-cycle infectious influenza A virus (sciIAV).

Authors:  Aitor Nogales; Steven F Baker; William Domm; Luis Martínez-Sobrido
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

8.  Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.

Authors:  Aitor Nogales; Marta L DeDiego; David J Topham; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

9.  Development of high-yield influenza B virus vaccine viruses.

Authors:  Jihui Ping; Tiago J S Lopes; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-05       Impact factor: 11.205

Review 10.  Implications of segment mismatch for influenza A virus evolution.

Authors:  Maria C White; Anice C Lowen
Journal:  J Gen Virol       Date:  2017-12-15       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.